يعرض 41 - 50 نتائج من 108 نتيجة بحث عن '"Sherbenou, Daniel"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 41
    A subset of chronic myelloid leukemia (CML) patients on ABL kinase inhibitor therapy develop point mutations outside the BCR-ABL kinase domain that decrease drug sensitivity and may have a role in disease progression

    المؤلفون: Sherbenou, Daniel W., Oliver Hantschel, Willis, Stephanie, Press, Richard D., Druker, Brian J., Superti-Furga, Giulio, Deininger, Michael W.

    المصدر: ResearcherID

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::953c87dd5c66849d444e586aeace83f1Test
    http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000242440002709&KeyUID=WOS:000242440002709Test


    أضف إلى المفضلة
  2. 42
    Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia

    المؤلفون: Sherbenou, Daniel W., Hantschel, Oliver J., Turaga, Lalita, Kaupe, Ines, Willis, Stephanie, Bumm, Thomas, Press, Richard D., Giulio Superti-Furga, Druker, Brian J., Deininger, Michael W.

    المصدر: ResearcherID

    مصطلحات موضوعية: hemic and lymphatic diseases, neoplasms, Sequence Deletion

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::34c14660d8f884e2f8847e845a615d88Test
    https://infoscience.epfl.ch/record/164356Test


    أضف إلى المفضلة
  3. 43
    دورية
    A Rapid Functional Screen for Small Molecule and Monoclonal Antibody Drug Sensitivity in Multiple Myeloma Patients

    المؤلفون: Walker, Zachary J, VanWyngarden, Michael J, Stevens, Brett M, Langouët-Astrie, Christophe, Smith, Clayton, Palmer, Brent E, Forsberg, Peter A, Mark, Tomer M, Jordan, Craig T, Sherbenou, Daniel W

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p3203-3203, 1p

    النص الكامل

    أضف إلى المفضلة
  4. 44
    دورية
    Chronic Graft Versus Host Disease Burden and Relapse Rates Are Lower with Comparable Overall Survival and Graft Versus Host Disease Free, Relapse Free Survival Following Adult Umbilical Cord Blood Compared to Matched Sibling Peripheral Blood Stem Cell Transplantation

    المؤلفون: Sharma, Prashant, Purev, Enkhtsetseg, Haverkos, Bradley M., Pollyea, Daniel A, Smith, Clayton, Kamdar, Manali, Sherbenou, Daniel W, Mark, Tomer M, Forsberg, Peter A, Gutman, Jonathan A

    المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p4660-4660, 1p

    النص الكامل

    أضف إلى المفضلة
  5. 45
    دورية
    Cellular Proliferation By Multiplex Immunohistochemistry Identifies Aggressive Disease Behavior in Relapsed Multiple Myeloma

    المؤلفون: Forsberg, Peter A., Mark, Tomer M, Sherbenou, Daniel W., Hammes, Andrew, Rossi, Adriana C., Niesvizky, Ruben, Jayabalan, David S, Ely, Scott

    المصدر: Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p3059-3059, 1p

    النص الكامل

    أضف إلى المفضلة
  6. 46
    دورية
    Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

    المؤلفون: Nooruddin, Zohra, Pan, Zenggang, Gross, Lilyana, David, Weitzenkamp, Haverkos, Bradley M., Pollyea, Daniel A, Gutman, Jonathan A, Robinson, William, Smith, Clayton, Schowinsky, Jeffrey, Enkhtsetseg, Purev, Sherbenou, Daniel W., Rabinovitch, Rachel, Ney, Douglas, Jordan, Craig T, Kamdar, Manali

    المصدر: Blood; December 2016, Vol. 128 Issue: 22 p3054-3054, 1p

    النص الكامل

    أضف إلى المفضلة
  7. 47
    دورية
    CD46 Is Amplified in High-Risk Myeloma with Gain of Chromosome 1q and Selectively Targeted By a Novel Anti-CD46 Antibody-Drug Conjugate

    المؤلفون: Sherbenou, Daniel W., Aftab, Blake T., Su, Yang, Behrens, Christopher R., Wiita, Arun P., Logan, Aaron C., Acosta-Alvear, Diego, Hann, Byron C., Walter, Peter, Wu, Xiaobo, Atkinson, John P., Wolf, Jeffrey L., Martin, Thomas G., Liu, Bin

    المصدر: Blood; December 2016, Vol. 128 Issue: 22 p384-384, 1p

    النص الكامل

    أضف إلى المفضلة
  8. 48
    دورية
    Characterization of BCR-ABL Deletion Mutants from Patients with Chronic Myeloid Leukemia.

    المؤلفون: Sherbenou, Daniel W., Hantschel, Oliver J., Turaga, Lalita, Mag, Ines Kaupe, Willis, Stephanie, Bumm, Thomas, Press, Richard D., Superti-Furga, Giulio, Druker, Brian J., Deininger, Michael W.

    المصدر: Blood; November 2007, Vol. 110 Issue: 11 p2936-2936, 1p

    النص الكامل

    أضف إلى المفضلة
  9. 49
    دورية
    A Subset of Chronic Myeloid Leukemia (CML) Patients on ABL Kinase Inhibitor Therapy Develop Point Mutations outside the BCR-ABL Kinase Domain That Decrease Drug Sensitivity and May Have a Role in Disease Progression.

    المؤلفون: Sherbenou, Daniel W., Hantschel, Oliver, Willis, Stephanie, Press, Richard D., Druker, Brian J., Superti-Furga, Giulio, Deininger, Michael W.

    المصدر: Blood; November 2006, Vol. 108 Issue: 11 p2188-2188, 1p

    النص الكامل

    أضف إلى المفضلة
  10. 50
    دورية
    In Chronic Myeloid Leukemia (CML) Patients with Complete Cytogenetic Response to Imatinib, BCR-ABL Kinase Domain Mutations Are Relatively Rare and Not Consistently Associated with Subsequent Relapse.

    المؤلفون: Sherbenou, Daniel W., Wong, Matthew J., Humayun, Adil, McGreevey, Laura S., Yang, Rui, Heinrich, Michael C., Press, Richard D., Druker, Brian J., Deininger, Michael W.

    المصدر: Blood; November 2005, Vol. 106 Issue: 11 p434-434, 1p

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث